IMCR

Immunocore Holdings Stock Analysis

AI Rating

Fair
  • Quality0/10
  • Growth↑ 6/10
  • Value↓ 1/10
Immunocore Holdings sales and earnings growth
IMCR Growth
Good
  • Revenue Y/Y↑ 28.95%
  • EPS Y/Y↑ 30.39%
  • FCF Y/Y↓ -171.91%
Immunocore Holdings gross and profit margin trends
IMCR Profitability
Neutral
  • Gross margin ↑ 98.70%
  • EPS margin↓ -8.90%
  • ROIC 5Y↓ -18.07%
Immunocore Holdings net debt vs free cash flow
IMCR Risk
Great
  • Debt / Equity↓ 1.1
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -0.6

Immunocore Holdings stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗